Personalized Medicine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.2 | Q4 | 14.0% | 0.357 | Q3 | 49.4% |
| 2024 | 1.8 | Q3 | 31.2% | 0.459 | Q3 | 59.4% |
| 2023 | 1.7 | Q3 | 30.4% | 0.412 | Q3 | 58.6% |
| 2022 | 2.3 | Q3 | 38.5% | 0.358 | Q3 | 56.0% |
| 2021 | 2.1 | Q4 | 38.7% | 0.564 | Q2 | 70.9% |
| 2020 | — | — | 0.489 | Q3 | 65.5% | |
| 2019 | — | — | 0.486 | Q2 | 66.7% | |
| 2018 | — | — | 0.312 | Q3 | 51.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1744-828X
ISSN
1741-0541
region
Western Europe
coverage
2006-2026